Effects of PPARγ Ligands on Vascular Tone
Journal:
Current Molecular Pharmacology
Volume:
5
Page:
282-291
Author(s):
Salvatore Salomone and Filippo Drago
The Tachykinergic System as Avenues for Drug Intervention
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
7
Page:
173-180
Author(s):
Pranela Rameshwar
Selective VEGFR Inhibitors for Anticancer Therapeutics in Clinical Use and Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
18
Page:
2921-2935
Author(s):
Cunlong Zhang, Chunyan Tan, Huaiwei Ding, Tian Xin and Yuyang Jiang
Emerging Therapies in Chronic Myeloid Leukemia
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
458-470
Author(s):
J. Gora-Tybor
Novel and Emerging Drugs for Chronic Lymphocytic Leukemia
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
471-483
Author(s):
S. Isfort, P. Cramer and M. Hallek
Novel and Emerging Drugs for Rarer Chronic Lymphoid Leukaemias
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
484-504
Author(s):
E. Matutes
Novel and Emerging Drugs for Acute Myeloid Leukemia
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
522-530
Author(s):
E. M. Stein and M. S. Tallman
New Strategies in the Chemotherapy of Leukemia: Eradicating Cancer Stem Cells in Chronic Myeloid Leukemia
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
571-596
Author(s):
A. Stefanachi, F. Leonetti, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, C. Altomare and A. Carotti
Novel and Emerging Drugs for Acute Lymphoblastic Leukemia
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
505-521
Author(s):
E. Lech-Maranda and W. Mlynarski
Editorial [Hot Topic: Novel and Emerging Drugs for Leukemias (Guest Editor: Tadeusz Robak)]
Journal:
Current Cancer Drug Targets
Volume:
12
Page:
453-457
Author(s):
Tadeusz Robak